+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Topoisomerase 3β is the major topoisomerase for mRNAs and linked to neurodevelopment and mental dysfunction



Topoisomerase 3β is the major topoisomerase for mRNAs and linked to neurodevelopment and mental dysfunction



Nucleic Acids Research 45(5): 2704-2713



Human cells contain five topoisomerases in the nucleus and cytoplasm, but which one is the major topoisomerase for mRNAs is unclear. To date, Top3β is the only known topoisomerase that possesses RNA topoisomerase activity, binds mRNA translation machinery and interacts with an RNA-binding protein, FMRP, to promote synapse formation; and Top3β gene deletion has been linked to schizophrenia. Here, we show that Top3β is also the most abundant mRNA-binding topoisomerase in cells. Top3β, but not other topoisomerases, contains a distinctive RNA-binding domain; and deletion of this domain diminishes the amount of Top3β that associates with mRNAs, indicating that Top3β is specifically targeted to mRNAs by its RNA binding domain. Moreover, Top3β mutants lacking either its RNA-binding domain or catalytic residue fail to promote synapse formation, suggesting that Top3β requires both its mRNA-binding and catalytic activity to facilitate neurodevelopment. Notably, Top3β proteins bearing point mutations from schizophrenia and autism individuals are defective in association with FMRP; whereas one of the mutants is also deficient in binding mRNAs, catalyzing RNA topoisomerase reaction, and promoting synapse formation. Our data suggest that Top3β is the major topoisomerase for mRNAs, and requires both RNA binding and catalytic activity to promote neurodevelopment and prevent mental dysfunction.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060408692

Download citation: RISBibTeXText

PMID: 28039324

DOI: 10.1093/nar/gkw1293


Related references

Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II. Proceedings of the National Academy of Sciences of the United States of America 82(21): 7178-7182, 1985

Inhibition of DNA topoisomerase II with etoposide induces association of DNA topoisomerase II alpha, DNA topoisomerase II beta, and nucleolin with BCR 2 of the ETO gene. Doklady. Biochemistry and Biophysics 423: 334-336, 2009

Quantitative immunocytochemical assays of topoisomerase II in lung adenocarcinoma cell lines: Correlation to topoisomerase II content and topoisomerase II catalytic activity. Acta Oncologica 35(4): 417-423, 1996

Kinetoplast-associated DNA topoisomerase in Crithidia fasciculata: crosslinking of mitochondrial topoisomerase II to both minicircles and maxicircles in cells treated with the topoisomerase inhibitor VP16. Nucleic Acids Research. July 11; 2013: 3353-3356, 1992

Topoisomerase II alpha content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines. Cancer ChemoTherapy and Pharmacology 39(3): 192-198, 1997

Quantitative immunocytochemical assays of topoisomerase II in lung adenocarcinoma cell lines. Correlation to topoisomerase II alpha content and topoisomerase II catalytic activity. Acta Oncologica 35(4): 417-423, 1996

Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth. Oncology Research 7(7-8): 407-416, 1995

Inhibition of DNA topoisomerase II with etoposide induces association of DNA topoisomerase II, DNA topoisomerase II, and nucleolin with BCR 2 of the ETO gene. Doklady Biochemistry and Biophysics 423(1): 334-336, 2008

Levels of DNA topoisomerase I, DNA topoisomerase IIalpha, and DNA topoisomerase IIbeta in human breast carcinomas. Proceedings of the American Association for Cancer Research Annual Meeting 39: 54, 1998

DNA topoisomerase I, DNA topoisomerase IIalpha, and DNA topoisomerase IIbeta as markers for human tumors. FASEB Journal 12(4): A197, March 17, 1998

Functional expression of human topoisomerase II-alpha in yeast: Mutations at amino acid 450 or 803 of topoisomerase II-alpha result in enzymes that can confer resistance to anti-topoisomerase II agents. Cancer Research 56(1): 91-99, 1996

Characterization of a human small cell lung cancer cell line resistant to topotecan, a topoisomerase I directed antitumor drug Decreased topoisomerase I and increased topoisomerase II level. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 457, 1994

Dysfunction of chromosomal loop attachment sites: illegitimate recombination linked to matrix association regions and topoisomerase II. Proceedings of the National Academy of Sciences of the United States of America 86(14): 5497-5501, 1989

Yeast topoisomerase II mutants resistant to anti-topoisomerase agents: identification and characterization of new yeast topoisomerase II mutants selected for resistance to etoposide. Cancer Research 54(11): 2943-2951, 1994

Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison. Molecular Pharmacology 67(2): 523-530, 2004